BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from NSAID toxicity simultaneously.
Key findingBPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from N
What the researchers found
BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from NSAID toxicity simultaneously.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.
European journal of pharmacology, 667(1-3), 322-9
Citation
Ilic, Spomenko; Drmic, Domagoj; Zarkovic, Kamelija; Kolenc, Danijela; Brcic, Luka; Radic, Bozo; Djuzel, Viktor; Blagaic, Alenka Boban; Romic, Zeljko; Dzidic, Senka; Kalogjera, Livije; Seiwerth, Sven; Sikiric, Predrag. (2011). Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.. European journal of pharmacology, 667(1-3), 322-9. https://doi.org/10.1016/j.ejphar.2011.05.038